BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Genelux Corporation 

3030 Bunker Hill Street, Suite 310

San Diego  California  92109  U.S.A.
Phone: 858-483-0024 Fax: 858-483-0026


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Genelux Corporation CEO, Dr. Aladar A. Szalay, To Give A Keynote Lecture At The 8th International Conference On Oncolytic Virus Therapeutics 4/9/2014 9:48:21 AM    More...
Genelux Corporation Appoints John D. Prunty Chief Financial Officer 2/11/2014 9:30:13 AM    More...
Genelux Corporation Release: Virus Engineered to Express Melanin Offers New Possibilities to Diagnose and Treat Solid Tumor Cancers 2/13/2013 10:41:19 AM    More...
First Patient Treated in Genelux Corporation Phase I Trial With GL-ONC1 at Memorial Sloan-Kettering Cancer Center 2/6/2013 6:48:04 AM    More...
Genelux Corporation Announces Early Results of a Phase I/II Clinical Trial of Virotherapeutic GL-ONC1 in Advanced Peritoneal Cavity Cancers 11/1/2012 11:13:24 AM    More...
Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients 6/28/2012 9:21:28 AM    More...
Genelux Corporation Announces First Patient Dosed in Phase I Combination Clinical Trial of GL-ONC1 6/14/2012 9:09:30 AM    More...
Genelux Corporation Announces Treatment of First Patient in Phase I/II Clinical Trial of GL-ONC1 in Advanced Peritoneal Cavity Cancers 5/31/2012 8:23:10 AM    More...
Genelux Corporation Announces Phase I Data Presentation at 2012 American Society of Clinical Oncology Annual Meeting of GL-ONC1, its Oncolytic Virus Lead Product Candidate 5/30/2012 11:41:21 AM    More...
Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors 8/5/2011 5:51:36 AM    More...
12

//-->